News & Updates
Showing Paediatrics articles
Showing
Show Multimedia Only

Nirsevimab prevents RSV-related hospitalizations, severe disease in infants
a day ago
byStephen Padilla
Treatment with nirsevimab has been shown to bring down the number of hospitalizations due to respiratory syncytial virus (RSV) infections and prevent the development of severe disease in infants, according to a study presented at ESPID 2026.








